Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Expert-led presentations & discussions on key abstracts in ALL from ASH 2022 The Post-ASH 2022 iwAL Virtual Workshop was held on 11-12 January 2023,...

VJHemOnc is pleased to bring you a feature exploring the latest thinking on the application of MRD in AML trials and treatment, with leading...

Claire Harrison, MD, FRCP, FRCPath, Guy’s and St Thomas’ NHS Foundation Trust, London, UK, describes the mechanism of action...

Mashup Score:3

VJHemOnc

Post-ASH 2022 iwMDS | VJHemOnc - 24 hours

Mashup Score:3

Expert-led presentations & discussions on key abstracts in myelodysplastic syndromes (MDS) from ASH 2022 The Post-ASH 2022 iwMDS Virtual Workshop was held on 12...

Krish Patel, MD, Swedish Cancer Institute, Seattle, WA, reports on results from a Phase II trial (NCT03736616) assessing acalabrutinib...

Ashutosh Wechalekar, MBBS, MD, FRCP, FRCPath, DM, University College London Hospitals NHS Foundation Trust, London, UK, comments on patient...

Expert-led presentations & discussions on key abstracts in lymphoma and chronic lymphocytic leukemia (CLL) from ASH 2022 The Post-ASH 2022 Lymphoma & CLL Virtual...

In this video, Eleni Gavriilaki, MD, PhD, G Papanikolaou Hospital, Thessaloniki, Greece, shares some updates on narsoplimab for the...

Jeremy Abramson, MD, Massachusetts General Hospital, Boston, MA, shares some insights into current immunotherapeutic agents being explored for the...

Mashup Score:1

VJHemOnc

Post-ASH 2022 iwMPNs | VJHemOnc - 3 days

Mashup Score:1

Expert-led presentations & discussions on key abstracts in MPNs from ASH 2022 The Post-ASH 2022 iwMPNs Virtual Workshop took place on 17 January 2023,...